IPA Guidance Document: “Safe Use of Platinum Group Metals in the Workplace”

The main health effect of concern for certain forms of platinum in industrial settings is respiratory sensitisation, commonly referred to as platinum salt sensitivity (PSS). It has almost exclusively been confined to workers exposed to certain compounds of platinum known as complex halogenated platinum salts (CHPS), of which chloroplatinates are the most common forms.

Most PGMs are integral to the workplaces in which they are used, and typically cannot be eliminated or readily substituted. The Guide therefore emphasises the proper control of soluble complex salts of platinum which are respiratory sensitisers by providing examples and suggestions for consideration in the design and implementation of occupational health and safety programs for worker protection.

NOTE: This Guide has been prepared by independent consultants in collaboration with specialists within the member companies of the IPA. Independent expert peer reviews and opinions have also been obtained. The Guide is not intended to be relied upon as a definitive or exhaustive source – readers are encouraged to obtain further information, such as that available in supplier safety datasheet. Furthermore, legal conditions and requirements are constantly evolving and readers are required to verify compliance with applicable local regulations related to worker medical surveillance (scroll down for "Conditions of Use and Disclaimer")

For more information please contact IPA (science@ipa-news.com)

Download of IPA Guidance Document

The Guidance Document "Safe Use of Platinum Group Metals in the Workplace" consists of ten chapters which can be downloaded individually (PDF):

Chapter 1 – Introduction and Executive Summary

Chapter 2 – Physical and Chemical Properties of Platinum Group Metals

Chapter 3 – Production and Uses of Platinum Group Metals

Chapter 4 – Sources of Exposure to Platinum Group Metals

Chapter 5 – Toxicokinetics of Platinum and other Platinum Group Metals

Chapter 6 – Toxicity of Platinum and Platinum Compounds (with summaries for other PGMs)

Chapter 7 – Medical Surveillance of Workers Exposed to Respiratory Sensitising Platinum Compounds

Chapter 8 – Workplace Monitoring

Chapter 9 – Control Measures and Management Systems

Chapter 10 – Workplace Regulatory Systems and Hazard Communication

FAQ: "Questions and Answers" – download here.

Press release: "Platinum Industry publishes Comprehensive Guide to the Safe use of Platinum Group Metals in the Workplace" – download here.

Conditions of Use and Disclaimer

This document should not be relied upon as a substitute for appropriate professional expertise. Furthermore, the information in this document does not constitute legal or mandatory advice. It is for information purposes only. The content of this document is based on the understanding of the circumstances as of today and updates may be required in the future. Any information or recommendation given is non-binding. Whilst reasonable precautions have been taken for the verification of the information in this present document, it is to be relied upon at the user´s own risk. No representations or warranties of any kind are made with regard to its completeness, reliability, usability or accuracy or possible typographical errors contained and in no event shall the IPA be liable for damages or losses of any kind arising from the use of this document or the reliance on it.

The user is therefore generally obliged to professionally check or to have professionally checked the suitability of the information in this present document for its intended use. This document in no way releases a company of its obligations to comply with legally binding rules and regulations. Companies must be aware that antitrust and competition laws may apply for several activities conducted by companies together.

The views and opinions expressed in this document do not necessarily state or represent those of the IPA.